FRONTIER BIOLABS LTD
Significant control: Patrick Maguire (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Frontier Biolabs Ltd sell?
Registered activity: Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (SIC 47749). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
FRONTIER BIOLABS LTD is an active private limited company (company number 15277903) incorporated on 13 November 2023, registered in London. Its registered activity is retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (SIC 47749). Latest small accounts cover the period ending 31 October 2025, showing net assets of £1.03m and cash of £338k, with 4 employees on average. Turnover was £10.04m. Net assets rose 122% on the prior period (£464k).
By net assets it sits in the top quarter of 232 comparable companies in London (median £1,050, upper quartile £26k).
Ownership and control
- Mr Patrick Maguire
- has significant influence or control
- Mr Mohammed Sajod Shafique
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mr Patrick Maguire
- has significant influence or control
- Mr Patrick Alan Dixon
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mr Mohammed Sajod Shafique
- has significant influence or control
- Mr Edward O'Brien
- owns 75–100% of shares
- Mr Aidan Gabriel Burns
- owns 75–100% of shares
- Mrs Margaret Maguire
- owns 75–100% of shares
- Mrs Margaret Maguire
- owns 75–100% of shares
- Mr Aidan Gabriel Burns
- owns 75–100% of shares
- Mr Jack Charlie Cardy
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 13 November 20232 yrs ago
- Next accounts due
- 31 July 2027in 281 days
- Confirmation statement due
- 27 November 2026in 35 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 47749
- Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c.
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 October 2025 | £1.03m | £338k | £214k | £27k | £10.04m | — | 4 |
| 30 November 2024 | £464k | — | — | £0 | — | — | 3 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £1,029,942 at 31 October 2025
- Net assets up 10% or more on the prior period+122.1% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 22.79
- Cash at bank of £50,000 or moreCash £337,810
- Incorporated two to five years agoIncorporated 13 November 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 281 days
- Confirmation statement duein 35 days
- Accounts period endNet assets £1.03m · small accounts
- Accounts period endNet assets £464k · small accounts
- Incorporated
Similar companies in London
Reminders for FRONTIER BIOLABS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.